JACKLYN OSBORN: Open Payments
NPI 1871209098 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 32 payments from 9 companies in 2025. Trend: 2023 $606 · 2024 $794 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $146 |
| Novo Nordisk Inc | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Amgen Inc. | 4 | $67 |
| PFIZER INC. | 3 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: INSPIRE, Wegovy, Kerendia, VERQUVO, REPATHA, LifeVest, JARDIANCE, ELIQUIS.
Industry payments across AL — which companies pay providers there.
